Close Menu

consumer genomics

Data collected from volunteers will be used in a genome-wide association study to better understand COVID-19.

Some of the market's most influential voices, including Kári Stefánsson and Linda Avey, believe that consumer genomics is not on the way out but rather experiencing a period of transition.

The company will offer a 32-gene polygenic score test to patients in the Osaka, Japan Nakanoshima Clinic, with reporting and patient support help from IxLayer.

CEO Margo Georgiadis said that the company has "seen a slowdown in consumer demand across the entire DNA category."

The company hopes to help consumer genomics firms and healthcare companies reduce the IT burdens associated with launching a new test.

The fledgling company, started as a promise to the founder's dying sister, is trying to succeed in a consumer niche where so many others have failed.

Despite the availability of more precision therapies and complex biomarker tests, systemic gaps and lack of physician education continued to hinder access.

The company will use the funding to market its GoodCell Diagnostics service, which combines genetic testing and personally controlled biobanking.

The clinical decision support content developer is integrating genetic testing information into its knowledgebase to assist physicians at the point of care.

Despite the step-up in FDA action against labs offering PGx tests, the success of these programs suggests that access to them isn't being stifled as some feared.

Pages

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.